Although GLP-1 RA or SGLT-2i combined with metformin have increased potency in reducing HbA1c, it has to be stated that the patients in the metformin group had lower HbA1c at the V0M, and also a decreased duration of DM. The gene discussed is GCG; the disease is diabetes mellitus.